We spoke to a number of blood cancer experts at the 2019 meeting of the American Society of Hematology (ASH).
In this video interview Dr Sara Ghorashian describes the remaining challenges in the treatment of childhood acute lymphoblastic leukaemia (ALL), and how these could be addressed. youtu.be/o4R9V5OeQoU